SI Group to Acquire Assets from Albemarle
SI Group agrees to purchase certain Albemarle assets and products.
SI Group reported that it has signed a deal to acquire the Antioxidants, Ibuprofen, and related businesses and assets from Albemarle Corporation. The transaction includes manufacturing sites in Orangeburg, South Carolina, andJinshan, China.
The acquisition will include Albemarle’s antioxidant product lines, as well as the Ibuprofen and Propofol businesses. In addition, applications and technical support capabilities in Shanghai and Baton Rouge, Louisiana will be included in the transaction. Subject to the required regulatory approvals, this acquisition is expected to be completed later this year.
Source: SI Group
UK Medicines Manufacturing Skills Centre Stresses Skill Development after Budget Announcement
November 8th 2024A £520 million investment for manufacturing capacity was announced by Chancellor of the Exchequer, Rachel Reeves, but academic and industry leaders stress the money should be used to train personnel.
